Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Psychol Med ; 50(10): 1727-1735, 2020 07.
Article in English | MEDLINE | ID: mdl-31328716

ABSTRACT

BACKGROUND: Previous research showed that automatic emotion regulation is associated with activation of subcortical areas and subsequent feedforward processes to cortical areas. In contrast, cognitive awareness of emotions is mediated by negative feedback from cortical to subcortical areas. Pregenual anterior cingulate cortex (pgACC) is essential in the modulation of both affect and alexithymia. We considered the interplay between these two mechanisms in the pgACC and their relationship with alexithymia. METHOD: In 68 healthy participants (30 women, age = 26.15 ± 4.22) we tested associations of emotion processing and alexithymia with excitation/inhibition (E/I) balance represented as glutamate (Glu)/GABA in the pgACC measured via magnetic resonance spectroscopy in 7 T. RESULTS: Alexithymia was positively correlated with the Glu/GABA ratio (N = 41, p = 0.0393). Further, cognitive self-awareness showed an association with Glu/GABA (N = 52, p = 0.003), which was driven by a correlation with GABA. In contrast, emotion regulation was only correlated with glutamate levels in the pgACC (N = 49, p = 0.008). CONCLUSION: Our results corroborate the importance of the pgACC as a mediating region of alexithymia, reflected in an altered E/I balance. Furthermore, we could specify that this altered balance is linked to a GABA-related modulation of cognitive self-awareness of emotions.


Subject(s)
Affective Symptoms/metabolism , Emotional Regulation/physiology , Gyrus Cinguli/physiology , Inhibition, Psychological , Adult , Brain Mapping , Cognition , Female , Glutamic Acid/analysis , Healthy Volunteers , Humans , Magnetic Resonance Spectroscopy , Male , Young Adult , gamma-Aminobutyric Acid/analysis
2.
Soc Cogn Affect Neurosci ; 11(2): 289-98, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26341904

ABSTRACT

Alexithymia, a personality construct marked by difficulties in processing one's emotions, has been linked to the altered activity in the anterior cingulate cortex (ACC). Although longitudinal studies reported sex differences in alexithymia, what mediates them is not known. To investigate sex-specific associations of alexithymia and neuronal markers, we mapped metabolites in four brain regions involved differentially in emotion processing using a point-resolved spectroscopy MRS sequence in 3 Tesla. Both sexes showed negative correlations between alexithymia and N-acetylaspartate (NAA) in pregenual ACC (pgACC). Women showed a robust negative correlation of the joint measure of glutamate and glutamine (Glx) to NAA in posterior cingulate cortex (PCC), whereas men showed a weak positive association of Glx to NAA in dorsal ACC (dACC). Our results suggest that lowered neuronal integrity in pgACC, a region of the default mode network (DMN), might primarily account for the general difficulties in emotional processing in alexithymia. Association of alexithymia in women extends to another region in the DMN-PCC, while in men a region in the salience network (SN) was involved. These observations could be representative of sex specific regulation strategies that include diminished internal evaluation of feelings in women and cognitive emotion suppression in men.


Subject(s)
Affective Symptoms/physiopathology , Emotions/physiology , Gyrus Cinguli/physiopathology , Nerve Net/physiopathology , Adult , Affective Symptoms/metabolism , Aspartic Acid/analogs & derivatives , Aspartic Acid/metabolism , Brain Mapping , Female , Glutamic Acid/metabolism , Gyrus Cinguli/metabolism , Humans , Male , Middle Aged , Nerve Net/metabolism , Sex Characteristics
3.
J Psychiatr Res ; 47(8): 1024-31, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23643103

ABSTRACT

Social phobia (SP) and panic disorder (PD) have been associated with aberrant amygdala responses to threat-related stimuli. The aim of the present study was to examine amygdala function and its connectivity with medial prefrontal cortex (mPFC) during emotional face perception in PD and SP, and the role of illness severity. Blood oxygen level dependent responses while perceiving emotional facial expressions were compared in 14 patients with PD, 17 patients with SP, 8 patients with comorbid PD and SP, and 16 healthy controls. We found that PD, but not SP, was associated with amygdala and lingual gyrus hypoactivation during perception of angry, fearful, happy and neutral faces, compared to healthy participants. No significant effect of PD and SP diagnoses was found on amygdala-mPFC connectivity. A positive correlation of anxiety symptom severity was found on amygdala-dorsal anterior cingulate and dorsal mPFC connectivity during perception of fearful faces. Amygdala hypoactivation suggests reduced responsiveness to positive and negative emotional faces in PD. Symptom severity, but not the presence of PD and SP diagnosis per se, explains most of the abnormalities in amygdala-mPFC connectivity during perception of fearful faces.


Subject(s)
Amygdala/physiopathology , Face , Facial Expression , Panic Disorder/pathology , Pattern Recognition, Visual/physiology , Phobic Disorders/pathology , Adolescent , Adult , Chi-Square Distribution , Female , Functional Laterality/physiology , Humans , Image Processing, Computer-Assisted , Magnetic Resonance Imaging , Male , Middle Aged , Netherlands , Photic Stimulation , Prefrontal Cortex/physiopathology , Psychiatric Status Rating Scales , Psychophysics , Young Adult
4.
Transl Psychiatry ; 2: e99, 2012 Apr 03.
Article in English | MEDLINE | ID: mdl-22832909

ABSTRACT

Major depressive disorder (MDD) is characterized by affective symptoms and cognitive impairments, which have been associated with changes in limbic and prefrontal activity as well as with monoaminergic neurotransmission. A genome-wide association study implicated the polymorphism rs2522833 in the piccolo (PCLO) gene--involved in monoaminergic neurotransmission--as a risk factor for MDD. However, the role of the PCLO risk allele in emotion processing and executive function or its effect on their neural substrate has never been studied. We used functional magnetic resonance imaging (fMRI) to investigate PCLO risk allele carriers vs noncarriers during an emotional face processing task and a visuospatial planning task in 159 current MDD patients and healthy controls. In PCLO risk allele carriers, we found increased activity in the left amygdala during processing of angry and sad faces compared with noncarriers, independent of psychopathological status. During processing of fearful faces, the PCLO risk allele was associated with increased amygdala activation in MDD patients only. During the visuospatial planning task, we found no genotype effect on performance or on BOLD signal in our predefined areas as a function of increasing task load. The PCLO risk allele was found to be specifically associated with altered emotion processing, but not with executive dysfunction. Moreover, the PCLO risk allele appears to modulate amygdala function during fearful facial processing in MDD and may constitute a possible link between genotype and susceptibility for depression via altered processing of fearful stimuli. The current results may therefore aid in better understanding underlying neurobiological mechanisms in MDD.


Subject(s)
Alleles , Cytoskeletal Proteins/genetics , Depressive Disorder, Major/genetics , Emotions/physiology , Executive Function/physiology , Genome-Wide Association Study , Genotype , Neuropeptides/genetics , Polymorphism, Genetic/genetics , Adult , Amygdala/physiopathology , Depressive Disorder, Major/physiopathology , Dominance, Cerebral/physiology , Facial Expression , Female , Genetic Carrier Screening , Genetic Predisposition to Disease/genetics , Humans , Image Enhancement , Image Interpretation, Computer-Assisted , Magnetic Resonance Imaging , Male , Middle Aged , Oxygen/blood , Pattern Recognition, Visual/physiology , Synaptic Transmission/genetics , Synaptic Transmission/physiology
5.
Psychol Med ; 41(11): 2253-64, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21557888

ABSTRACT

BACKGROUND: Depression has been associated with limbic hyperactivation and frontal hypoactivation in response to negative facial stimuli. Anxiety disorders have also been associated with increased activation of emotional structures such as the amygdala and insula. This study examined to what extent activation of brain regions involved in perception of emotional faces is specific to depression and anxiety disorders in a large community-based sample of out-patients. METHOD: An event-related functional magnetic resonance imaging (fMRI) paradigm was used including angry, fearful, sad, happy and neutral facial expressions. One hundred and eighty-two out-patients (59 depressed, 57 anxiety and 66 co-morbid depression-anxiety) and 56 healthy controls selected from the Netherlands Study of Depression and Anxiety (NESDA) were included in the present study. Whole-brain analyses were conducted. The temporal profile of amygdala activation was also investigated. RESULTS: Facial expressions activated the amygdala and fusiform gyrus in depressed patients with or without anxiety and in healthy controls, relative to scrambled faces, but this was less evident in patients with anxiety disorders. The response shape of the amygdala did not differ between groups. Depressed patients showed dorsolateral prefrontal cortex (PFC) hyperactivation in response to happy faces compared to healthy controls. CONCLUSIONS: We suggest that stronger frontal activation to happy faces in depressed patients may reflect increased demands on effortful emotion regulation processes triggered by mood-incongruent stimuli. The lack of strong differences in neural activation to negative emotional faces, relative to healthy controls, may be characteristic of the mild-to-moderate severity of illness in this sample and may be indicative of a certain cognitive-emotional processing reserve.


Subject(s)
Amygdala/physiopathology , Anxiety Disorders/psychology , Depressive Disorder/psychology , Emotions , Facial Expression , Social Perception , Adult , Amygdala/drug effects , Anger , Anxiety Disorders/drug therapy , Anxiety Disorders/epidemiology , Anxiety Disorders/physiopathology , Brain Mapping , Case-Control Studies , Comorbidity , Depressive Disorder/drug therapy , Depressive Disorder/epidemiology , Depressive Disorder/physiopathology , Fear , Female , Humans , Magnetic Resonance Imaging , Male , Netherlands , Psychotropic Drugs/pharmacology
6.
Acta Psychiatr Scand ; 124(4): 273-84, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21480834

ABSTRACT

OBJECTIVE: Major depressive disorder (MDD) has been associated with executive dysfunction and related abnormal prefrontal activity, whereas the status of executive function (EF) in frequently co-occurring anxiety disorders and in comorbid depression-anxiety is unclear. We aimed to study functional MRI correlates of (visuospatial) planning in MDD and anxiety disorders and to test for the effects of their comorbidity. METHOD: Functional MRI was employed during performance of a parametric Tower of London task in out-patients with MDD (n = 65), MDD with comorbid anxiety (n = 82) or anxiety disorders without MDD (n = 64), and controls (n = 63). RESULTS: Moderately/severely depressed patients with MDD showed increased left dorsolateral prefrontal activity as a function of task load, together with subtle slowing during task execution. In mildly depressed and remitted MDD patients, in anxiety patients, and in patients with comorbid depression-anxiety, task performance was normal and no activation differences were observed. Medication use and regional brain volume were not associated with altered visuospatial planning. CONCLUSION: Prefrontal hyperactivation during high planning demands is not a trait characteristic, but a state characteristic of MDD without comorbid anxiety, occurring independent of SSRI use. Disturbances in planning or the related activation are probably not a feature of anxiety disorders with or without comorbid MDD, supporting the current distinction between anxiety disorders and depression.


Subject(s)
Anxiety Disorders/physiopathology , Brain/physiopathology , Depressive Disorder, Major/physiopathology , Magnetic Resonance Imaging , Task Performance and Analysis , Adult , Case-Control Studies , Female , Humans , Male , Neuroimaging , Neuropsychological Tests , Prefrontal Cortex/physiopathology , Severity of Illness Index
SELECTION OF CITATIONS
SEARCH DETAIL
...